Property | Value |
?:abstract
|
-
The Centers for Medicare & Medicaid Services (CMS) and other federal agencies are busy churning out regulations and guidance documents in response to the COVID-19 crisis. CMS now requires plans to waive cost sharing for COVID-19-related immunizations, testing, and treatment and suspend utilization review requirements related to drug-supply limits unless these limits are related to patient safety.
|
?:creator
|
|
?:doi
|
|
?:doi
|
|
?:journal
|
-
The_Senior_care_pharmacist
|
?:license
|
|
?:pmid
|
|
?:pmid
|
|
?:publication_isRelatedTo_Disease
|
|
?:source
|
|
?:title
|
-
CMS Responds to COVID-19 Crisis by Revising Regulations.
|
?:type
|
|
?:year
|
|